O
Olema
In HouseOlema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with best-in-class potential.
Hiring by Category
Legal3Operations2
Promote your listings on LegalTech Roles
Get featured placement, priority search ranking, and newsletter distribution for your job listings.
Open Positions (3)
Senior Manager, Legal Operations & Contracts
Olema
πΊπΈ Boston, Massachusetts
Full TimeOn-siteLegalOperations
3 weeks ago
Senior Manager, Legal Operations & Contracts
Olema
πΊπΈ San Francisco, California
Full TimeOn-siteLegalOperations
3 weeks ago
Legal Intern
Olema
πΊπΈ Cambridge, Massachusetts
$0 - $0 Hourly
InternshipOn-siteLegal
1 month ago